New Toronto imaging center to focus on addiction, mental illness

The Centre for Addiction and Mental Health (CAMH) in Toronto will open the doors to its new Research Imaging Centre, where PET, MRI and genetic imaging will be focused on the study of addictions and mental illness.

Over the past two years, CAMH's research facilities have undergone development and construction to accommodate a brain imaging capacity, adding 5,700 square feet to its research wing. From depression and schizophrenia to Alzheimer's disease and addictions, the new facility will allow CAMH scientists to combine technologies in novel ways to learn more about how neurological and mental disorders affect brain function.


 

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.